Cargando…
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
SIMPLE SUMMARY: Many more people are dying each year from primary liver cancers arising in obesity-related fatty liver disease. Often these cancers are a consequence of fatty liver disease progression, with inflammation, scarring and cirrhosis. Less often, cancers develop in the presence of fat with...
Autores principales: | Eldafashi, Nardeen, Darlay, Rebecca, Shukla, Ruchi, McCain, Misti Vanette, Watson, Robyn, Liu, Yang Lin, McStraw, Nikki, Fathy, Moustafa, Fawzy, Michael Atef, Zaki, Marco Y. W., Daly, Ann K., Maurício, João P., Burt, Alastair D., Haugk, Beate, Cordell, Heather J., Bianco, Cristiana, Dufour, Jean-François, Valenti, Luca, Anstee, Quentin M., Reeves, Helen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003582/ https://www.ncbi.nlm.nih.gov/pubmed/33808740 http://dx.doi.org/10.3390/cancers13061412 |
Ejemplares similares
-
NAFLD-Associated HCC: Progress and Opportunities
por: Geh, Daniel, et al.
Publicado: (2021) -
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
por: Dongiovanni, Paola, et al.
Publicado: (2013) -
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016) -
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021) -
PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)